- Research Article
1
- 10.1016/j.jpsychires.2026.02.015
The role of IDO1-mediated Tryptophan/Kynurenine metabolism and its association with estrogen level in PTSD within SPS mouse model.
- May 01, 2026
- Journal of psychiatric research
- Lu Zhang + 5 more +5
Publications from 2021 to 2026
Showing 10 of 168 papers
The role of IDO1-mediated Tryptophan/Kynurenine metabolism and its association with estrogen level in PTSD within SPS mouse model.
A closed-loop comprehensive analysis of global burden data, future projections, risk factors, and molecular mechanisms on nasopharyngeal carcinoma
Background: Nasopharyngeal carcinoma (NPC), a frequent malignant tumor, exhibits a high propensity for both metastasis and recurrence. This study provided a comprehensive analysis of the burden, risk factors, and potential molecular mechanisms of NPC. Methods: Utilizing data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, we analyzed NPC burden in relation to age, sex, risk factors, and the sociodemographic index (SDI). The average annual percent change (AAPC) was computed through joinpoint regression. To assess causal links between risk factors and NPC, we employed two-sample Mendelian randomization (MR). Future NPC incidence trends (2022–2050) were projected using the Bayesian age–period–cohort model. We also elucidated the molecular mechanisms that trigger NPC by a bioinformatics analysis. Results: Global NPC mortality (AAPC: −1.817) and disability-adjusted life years (DALYs) rates (AAPC: −1.932) declined from 1990 to 2021. However, rising prevalence (AAPC: +0.317) and persistent high burden in East/Southeast Asia [e.g., Malaysia age-standardized incidence rate (ASIR): 6.09/100 000]. Socioeconomic disparities are widening, with low-SDI regions experiencing slower burden reduction. Projections suggest continued ASIR decline to 1.08/100 000 by 2050. MR analysis confirms smoking as a causal risk [current smokers odds ratio (OR) = 3.10; former smokers OR = 7.00, compared to never smoking], while Secretoglobin family 1A member 1 (SCGB1A1) downregulation emerges as a key mechanistic link-driving immunosuppression via Th2/Treg infiltration and hub genes (CXCL11, CD19). Conclusion: We innovatively constructed a closed-loop on NPC by multiple bioinformatic techniques. Global NPC mortality and DALYs have significantly declined, while this progress is counterbalanced by a rising prevalence and persistently high burden in East/Southeast Asia. Smoking was detected as a strong causal risk factor for NPC, while SCGB1A1 downregulation served as a novel key molecular driver of NPC pathogenesis.
Read moreSynthesize contrast-enhanced ultrasound image of thyroid nodules via generative adversarial networks.
This study aims to explore the feasibility of employing generative adversarial networks (GAN) to generate synthetic contrast-enhanced ultrasound (CEUS) from grayscale ultrasound images of patients with thyroid nodules while dispensing with the need for ultrasound contrast agents injection. Patients who underwent preoperative thyroid CEUS examinations between January 2020 and July 2022 were collected retrospectively. The cycle-GAN framework integrated paired and unpaired learning modules was employed to develop the non-invasive image generation process. The syntheticCEUS imageswas generated in three phases: pre-arterial, plateau, and venous. The evaluation included quantitative similarity metrics, classification performance, and qualitative assessment by radiologists. CEUS videos of 360 thyroid nodules from 314 patients (45 years ± 12 [SD]; 272 women) in the internal dataset and 202 thyroid nodules from 183 patients (46 years ± 13 [SD]; 148 women) in the external dataset were included. In the external testing dataset, quantitative analysis revealed a significant degree of similarity between real and synthetic CEUS images (structure similarity index, 0.89 ± 0.04; peak signal-to-noise ratio, 28.17 ± 2.42). Radiologists deemed 126 of 132 [95%] synthetic CEUS images diagnostically useful. The accuracy of radiologists in distinguishing between real and synthetic images was 55.6% (95% CI: 0.49, 0.63), with an AUC of 61.0% (95% CI: 0.65, 0.68). No statistically significant difference (p > 0.05) was observed when radiologists assessed peak intensity and enhancement patterns using real CEUS and synthetic CEUS. Both quantitative analysis and radiologist evaluations exhibited that synthetic CEUS images generated by generative adversarial networks were similar to real CEUS images. QuestionIt is feasible to generate synthetic thyroid contrast-enhanced ultrasound images using generative adversarial networks without ultrasound contrast agents injection. FindingsCompared to real contrast-enhanced ultrasound images, synthetic contrast-enhanced ultrasound images exhibited high similarity and image quality. Clinical relevanceThis non-invasive and intelligent transformation may reduce the requirement for ultrasound contrast agents in certain cases, particularly in scenarios where ultrasound contrast agents administration is contraindicated, such as in patients with allergies, poor tolerance, or limited access to resources.
Read moreAbstract PS5-12-28: Human Development Index and Breast Cancer Prognosis in Chinese Women: A Multiregional Survival Analysis
Abstract Background: Breast cancer is the most commonly diagnosed cancer among women in China and globally. Significant regional disparities in survival outcomes have been observed, potentially influenced by socioeconomic development. The Human Development Index (HDI) is a composite measure of health, education, and income that may reflect healthcare access and quality, yet its association with breast cancer prognosis remains unclear in China. Objective: To evaluate the association between regional HDI and survival outcomes in Chinese women with breast cancer, and to quantify the impact of incremental HDI improvement on prognosis. Methods: A multicenter retrospective cohort study included 25,514 patients from 40 cancer centers across 184 prefecture-level cities in China. Regional HDI values were extracted from the China Human Development Report Special Edition. The primary outcomes were overall survival (OS) and progression-free survival (PFS). Survival curves were estimated by using the Kaplan-Meier . Multivariable Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CI), adjusting for tumor stage, molecular subtype, Ki67 status, age, and pathological type. HDI was analyzed per 0.05-unit increase, corresponding to one standard deviation. Results: Patients in high-HDI regions had significantly better PFS and OS than they in low-HDI. 4-year PFS was 92.4% versus 88.4%, 8-year PFS 86.2% versus 72.6%, and 12-year PFS 83.2% versus 57.9% (log-rank P < 0.001). And 4-year OS was 97.0% versus 93.4%, 8-year OS 94.6% versus 87.0%, and 12-year OS 93.2% versus 84.5% (P < 0.001). After adjustments, each 0.05-unit increase in HDI was associated with a 14% reduction in mortality risk (HR = 0.861, 95% CI: 0.807-0.919; P < 0.001), and the similar reduction was observed for recurrence risk (HR = 0.884, 95% CI: 0.847-0.923; P < 0.001). The association remained consistent across molecular subtypes. We provide the first quantitative evidence of the independent association between HDI and both OS and PFS in a national breast cancer cohort. Conclusions: Higher regional HDI is independently associated with improved survival in Chinese women with breast cancer. Each 0.05-unit increase in HDI confers a clinically meaningful survival benefit. These findings underscore the role of socioeconomic development in cancer outcomes and support targeted interventions to reduce regional disparities in care access and quality. Citation Format: W. Wang, Y. Yuan, A. Yuan, Z. Hu, C. Zheng, Z. Zheng, Y. Pan, W. Liang, B. Chen, C. Zhang, Y. Zhang. Human Development Index and Breast Cancer Prognosis in Chinese Women: A Multiregional Survival Analysis [abstract]. In: Proceedings of the San Antonio Breast Cancer Symposium 2025; 2025 Dec 9-12; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2026;32(4 Suppl):Abstract nr PS5-12-28.
Read moreAbstract RF2-03: Adjuvant epirubicin plus cyclophosphamide followed by taxanes with or without carboplatin for early stage triple-negative breast cancer (RJBC 1501): a randomized controlled phase III trial
Abstract Background: RJBC 1501 (NCT02455141) is a prospective phase III study to compare the efficacy and safety of adjuvant epirubicin plus cyclophosphamide (EC) followed by taxanes (T) versus same regimen plus carboplatin (EC-TCb) in early-stage triple negative breast cancer (TNBC). Methods: Patients with node positive or node negative (with tumor size ≥1.0cm) TNBC who received definitive surgery were randomized 1:1 to receive EC-T or EC-TCb. Taxanes consisted of either weekly paclitaxel for 12 doses or docetaxel every 3 weeks for 4 cycles. Carboplatin was given weekly (AUC 2) for 12 doses or every 3 weeks (AUC 5-6) for 4 cycles, concurrent with taxanes. The primary endpoint was disease-free survival (DFS) in the intention-to-treat (ITT) population. Secondary endpoint includes distant DFS (DDFS), overall survival (OS), and safety. Results: Between March 2016 and March 2023, 786 patients were randomized (EC-T: n = 391; EC-TCb: n = 395). Baseline characteristics were balanced: median age ≤50 years (49.6%), T1 stage (46.6%), node-negative (72.3%). A majority of patients (76.5%) received 3-weekly docetaxel. After a median follow up of 4.52 (IQR 2.83 to 6.06) years, 103 events were reported: 62 in the EC-T group and 41 in the EC-TCb group. Addition of carboplatin significantly improved DFS (hazard ratio [HR], 0.66; 95% CI, 0.44 to 0.97, P = 0.034), with 3-year DFS of 89.8% (95%CI 86.8 to 92.9%) for EC-T and 93.1% (95%CI 90.5 to 95.7%) for EC-TCb. EC-TCb regimen was also associated with a superior DDFS (HR, 0.61; 95% CI, 0.38 to 0.98, P = 0.040) and OS (HR, 0.39; 95% CI 0.16 to 0.94, P = 0.029) compared to EC-T treatment. Grade 3-4 adverse events were more frequent among EC-TCb arm (49.9%) than EC-T arm (38.7%), primarily driven by higher rates of neutropenia (47.0% vs 37.8%) and thrombocytopenia (4.5% vs 0%). Other grade 3-4 toxicities were comparable between groups. Conclusion: Adding carboplatin to adjuvant EC-T chemotherapy significantly improves DFS, DDFS, and OS in patients with early-stage TNBC. While additional carboplatin treatment was associated with increased hematologic toxicity, no new safety signals emerged. Citation Format: X. Chen, J. Huang, H. Shi, J. Zhu, W. Wu, G. Ye, Q. He, Y. Shi, A. Zhang, X. Xie, X. Wang, X. Chen, W. Wu, J. Wu, Z. Li, Z. Li, Y. Dai, W. Ren, Q. Shao, Y. Chen, Y. Zeng, M. Pegram, K. Shen. Adjuvant epirubicin plus cyclophosphamide followed by taxanes with or without carboplatin for early stage triple-negative breast cancer (RJBC 1501): a randomized controlled phase III trial [abstract]. In: Proceedings of the San Antonio Breast Cancer Symposium 2025; 2025 Dec 9-12; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2026;32(4 Suppl):Abstract nr RF2-03.
Read moreSurgical treatment of type A interrupted aortic arch in an adult male
Structure-aware generalization for heterogeneous histopathology via prototype-based multiple instance learning
Accurate and generalizable cancer diagnosis from whole slide images (WSIs) remains challenging due to limited fine-grained annotations, complex tumor architectures, and domain shifts across scanners and institutions1. We introduce StructMIL, a structure-aware and prototype-driven multiple instance learning framework designed for robust and interpretable cancer detection and grading2. StructMIL integrates graph-based topological priors with histological context, employs prototype-enhanced pooling for stable and transparent predictions, and incorporates a unified domain-generalization strategy that combines contrastive alignment, adversarial confusion, and consistency regularization. Evaluated on Camelyon16 for breast cancer metastasis detection and PANDA for prostate cancer Gleason grading, StructMIL achieves state-of-the-art performance. On Camelyon16, StructMIL improves cross-center AUC by +3.2% over standard MIL baselines, reaching an AUC of 0.967. On PANDA, it improves cross-scanner Gleason grading robustness with a +7.4% Cohen’s Kappa gain compared with prior MIL models, demonstrating substantially reduced performance degradation under domain shift. StructMIL further provides interpretable prototype-based attribution maps that highlight biologically meaningful structures more reliably than conventional MIL and graph-free approaches3. By jointly improving accuracy, interpretability, and generalization across scanners and medical centers, StructMIL offers a practical and clinically aligned solution for large-scale deployment in multi-center computational pathology workflows4.
Read moreMRI-based intratumoral and peritumoral radiomics predicting neoadjuvant chemotherapy response in osteosarcoma
ObjectivesTo evaluate the predictive performance of a nomogram that integrates intratumoral and peritumoral MRI-based radiomics with clinical variables for assessing the efficacy of neoadjuvant chemotherapy (NAC) in patients with osteosarcoma (OS).MethodsThis retrospective study included 93 patients with pathologically confirmed OS who underwent standard NAC. Intratumoral regions were manually segmented on axial T2-weighted fat-suppressed (T2WI-FS) images using ITK-SNAP, and peritumoral regions were generated semi-automatically by isotropic expansions of 2 mm, 4 mm, and 6 mm. Random forest classifiers were constructed separately for intratumoral, peritumoral, and combined intratumoral-peritumoral radiomics features. The optimal radiomics model was incorporated with significant clinical predictors to build an individualized nomogram. Model performance was assessed through the F1 score, Delong’s test and receiver operating characteristic (ROC) curve analysis. Decision curve analysis (DCA) was applied to assess the model’s clinical utility.ResultsMultivariate logistic regression identified alkaline phosphatase (ALP) (OR = 1.003, 95% CI: 1.000 ~ 1.006, P = 0.031) and pathological fracture (PF)(OR = 2.575, 95% CI: 1.036 ~ 6.401, P = 0.042) as independent predictors of NAC response. Among all radiomics models, the Model_rad-intra + peri2mm combination model demonstrated the best performance, achieving AUCs of 0.888 in the training set and 0.765 in the test set. The integrated nomogram further improved predictive accuracy, with AUC of 0.990 and 0.815 in the training and test sets, respectively.ConclusionWe developed and validated a nomogram that combines intratumoral and peritumoral MRI radiomics with clinical variables for predicting NAC efficacy in OS. The model demonstrated robust performance and may support early, individualized treatment evaluation and clinical decision-making in patients undergoing NAC.
Read moreConstruction of an early diagnostic model for pulmonary hypertension based on aging-related signature genes and identification of potential therapeutic targets.
Pulmonary hypertension (PH) is a progressive cardiopulmonary disorder. It features elevated pulmonary arterial pressure, which leads to right ventricular failure and increased mortality. PH's insidious nature, with no specific clinical symptoms, hinders early diagnosis. Recent investigations have implicated vascular cell senescence in the pathogenesis of PH; however, the identification of early diagnostic biomarkers and the development of senescence-targeted therapeutics remain areas of unmet need.In this study, an integrative transcriptomic analysis of multiple datasets was undertaken to delineate differentially expressed senescence-related genes (DESRGs). Feature genes were selected via the implementation of LASSO regression, random forest, and support vector machine algorithms. Subsequently, a diagnostic nomogram was constructed, predicated on six hub genes. The discriminative capacity of the nomogram was rigorously validated utilizing external datasets. Single-gene gene set enrichment analysis (GSEA) was executed to elucidate potential biological functions. The expression profiles of core genes were corroborated through single-cell RNA sequencing and qPCR in an in vitro hypoxia model of pulmonary artery smooth muscle cells. Finally, connectivity map (cMAP) analysis and molecular docking were employed to identify potential therapeutic small molecules.The analysis identified 20 DESRGs. Six feature genes (LCN2, CBS, ABCB1, NQO1, TWIST1, TLR8) were consistently selected by all three machine learning methods. The diagnostic nomogram exhibited an area under the curve (AUC) of 0.974 in the training cohort and demonstrated robust performance in independent validation cohorts. Notably, CBS, TLR8, and NQO1 were significantly downregulated in validation datasets, single-cell sequencing, and the in vitro hypoxia model. GSEA revealed significant enrichment of innate immune responses, the IL-17 pathway, and oxidative stress. cMAP analysis identified TUL-XXI039 as a potential therapeutic compound, with molecular docking studies predicting strong binding affinities (binding energies < -8.0kcal/mol) to CBS, TLR8, and NQO1.This study introduces a novel, high-precision diagnostic model for PH based on senescence-related genes, underscoring CBS, TLR8, and NQO1 as promising biomarker candidates. TUL-XXI039 emerges as a potential multi-target therapeutic candidate for PH, thus meriting further investigation.
Read moreLumbar centroid level subcutaneous fat volume increased performance of prognostic predictive model in digestive system cancers: a real-world cohort study
BackgroundNutritional indicators play an important role in predicting the prognosis of digestive system cancers. Measures of adipose tissue distribution derived from computed tomography (CT), such as subcutaneous fat volume, are promising for assessing systemic inflammation and nutritional status. However, their integration into standardized prognostic models is still limited. This study aimed to increase the performance of the Cox regression model (Coxm) by adding the third lumbar vertebra centroid level subcutaneous fat volume (L3 CLSFV) and to assess its influence on prognostic prediction model.MethodsWe constructed two Cox regression models, Coxm1 and Coxm2, using clinical features and nutritional indicators from the training cohort of patients with digestive system cancers. The Coxm1 model contained seven features, while Coxm2 incorporated an extra L3 CLSFV measured by CT. Performance was evaluated using multiple metrics in the validation cohort, including time-dependent receiver operating characteristic (timeROC), time-dependent concordance index (timeC-index), calibration curve, and Kaplan-Meier curve. The predictive accuracy of the model was further assessed using net reclassification improvement (NRI) and integrated discrimination improvement (IDI).ResultsBoth models had high area under the curve (AUC) (range, 0.78–0.89) and C-index values (range, 0.74–0.80). The timeROC curve showed that the inclusion of L3 CLSFV in Coxm2 did not improve the model’s AUC, with similar values observed at 1-, 3-, and 5-year. Coxm2 did not improve time-dependent C-index in comparison with Coxm1. Calibration curves showed good agreement between predicted and actual survival probability in both models, with slight improvements seen in Coxm2 versus Coxm1 (Brier score, 0.166 vs. 0.168). NRI indicated that the inclusion of L3 CLSFV in Coxm2 improved the model’s performance. The category NRI of Coxm2 versus Coxm1 was 0.0768 [95% confidence interval (CI): −0.0768 to 0.128], while the continuous NRI was 0.0639 (95% CI: −0.0363 to 0.293). The IDI of Coxm2 versus Coxm1 was 0.006 (95% CI: −0.003 to 0.028). In the Kaplan-Meier curves, both Coxm1 and Coxm2 were accurately differentiated between high- and low-risk groups.ConclusionsThe addition of the L3 CLSFV to the Cox model improved the predictive accuracy and reclassification ability. These findings suggest that incorporating extra nutritional indicators can enhance the performance of prognostic models in digestive system cancer.
Read more